This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Cuiling Zhong: Innovator in Angiogenesis Inhibition
Introduction
Cuiling Zhong is a prominent inventor based in Palo Alto, CA. He has made significant contributions to the field of medical research, particularly in the area of angiogenesis inhibition. His work focuses on the prevention and treatment of tumor angiogenesis, which is crucial for cancer therapy.
Latest Patents
Cuiling Zhong holds a patent related to the inhibition of inflammatory cell-mediated angiogenesis. This invention specifically addresses the prevention or treatment of tumor angiogenesis using Bv8 antagonists, such as anti-Bv8 antibodies. His innovative approach has the potential to inhibit tumor development effectively.
Career Highlights
Zhong is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to further his research and contribute to advancements in cancer treatment.
Collaborations
Cuiling Zhong has collaborated with notable colleagues, including Napoleon Ferrara and Xiumin Wu. These partnerships have enhanced his research efforts and contributed to the development of effective therapeutic strategies.
Conclusion
Cuiling Zhong's work in angiogenesis inhibition represents a significant advancement in cancer research. His innovative patent and collaborations with esteemed colleagues highlight his commitment to improving treatment options for patients.